PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PUREGet Rating) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 5,800 shares, a drop of 55.0% from the April 30th total of 12,900 shares. Based on an average daily volume of 31,700 shares, the days-to-cover ratio is currently 0.2 days.

PURE Bioscience Stock Performance

Shares of OTCMKTS PURE remained flat at $0.11 during mid-day trading on Friday. 8,967 shares of the stock were exchanged, compared to its average volume of 37,358. The company has a market capitalization of $12.29 million, a PE ratio of -2.76 and a beta of 0.20. The business has a fifty day moving average of $0.12 and a 200-day moving average of $0.13. PURE Bioscience has a 52-week low of $0.07 and a 52-week high of $0.24.

PURE Bioscience (OTCMKTS:PUREGet Rating) last released its quarterly earnings results on Friday, March 17th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.40 million for the quarter. PURE Bioscience had a negative net margin of 228.72% and a negative return on equity of 142.15%.

PURE Bioscience Company Profile

(Get Rating)

PURE Bioscience, Inc engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.

See Also

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.